Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$0.16 - $0.44 $32 - $88
-200 Reduced 0.04%
449,600 $71,000
Q3 2023

Nov 14, 2023

BUY
$0.34 - $0.65 $4,556 - $8,710
13,400 Added 3.07%
449,800 $197,000
Q2 2023

Aug 14, 2023

SELL
$0.37 - $1.88 $851 - $4,324
-2,300 Reduced 0.52%
436,400 $161,000
Q1 2023

May 15, 2023

SELL
$1.75 - $2.7 $30,275 - $46,710
-17,300 Reduced 3.79%
438,700 $798,000
Q4 2022

Feb 14, 2023

BUY
$1.72 - $4.1 $1,892 - $4,510
1,100 Added 0.24%
456,000 $943,000
Q3 2022

Nov 14, 2022

SELL
$2.92 - $4.88 $364,124 - $608,536
-124,700 Reduced 21.51%
454,900 $1.37 Million

Others Institutions Holding HLTH

About Cue Health Inc.


  • Ticker HLTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 148,152,992
  • Description
  • Cue Health Inc., a healthcare technology company, designs and develops diagnostic platform for diagnostic tests for individuals, enterprises, healthcare providers and payors, and public health agencies. The company offers Cue Integrated Care platform comprising hardware and software components, such as Cue Health Monitoring System consisting of ...
More about HLTH
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.